Current Pharmaceutical Biotechnology
Volume 23, 15 Issues, 2022
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access
Contents
Current Pharmaceutical Biotechnology , Volume 17 - Number 1
Editorial
Preface
Editorial
Editorial (Thematic Issue: Toward Personalized Treatment for Acute Myeloid Leukemia)
, 17(1): 4 - 5Frode Selheim and Lars Herfindal
DOI: 10.2174/138920101701151027165031
The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
, 17(1): 6 - 19Rakel B. Forthun, Carina Hinrichs, Tara H. Dowling, Øystein Bruserud and Frode Selheim
DOI: 10.2174/1389201016666150907113653
Development of personalized molecular therapy for acute myeloid leukemia
, 17(1): 20 - 29Caroline B.N. Engen, Ehsan Hajjar and Bjørn T. Gjertsen
DOI: 10.2174/1389201016666150930115024
The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.
, 17(1): 30 - 41Félix Sauvage, Gillian Barratt, Lars Herfindal and Juliette Vergnaud-Gauduchon
DOI: 10.2174/1389201016666150817095045
Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies.
, 17(1): 42 - 51Pascal Gelebart, Mihaela Popa and Emmet McCormack
DOI: 10.2174/1389201016666150817095703
Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
, 17(1): 52 - 70Elise Aasebø, Rakel B. Forthun, Frode Berven, Frode Selheim and Maria Hernandez-Valladares
DOI: 10.2174/1389201016666150826115626
Screening for Marine Natural Products with Potential as Chemotherapeutics for Acute Myeloid Leukemia
, 17(1): 71 - 77Espen Hansen and Jeanette H. Andersen
DOI: 10.2174/1389201016666150817095537
Cyanobacteria as a Source for Novel Anti-Leukemic Compounds
, 17(1): 78 - 91Anu Humisto, Lars Herfindal, Jouni Jokela, Antti Karkman, Ronja Bjørnstad, Romi R. Choudhury and Kaarina Sivonen
DOI: 10.2174/1389201016666150826121124
Nutrition in Allogeneic Stem Cell Transplantion - Clinical Guidelines and Immunobiological Aspects
, 17(1): 92 - 104Tor H.A. Tvedt, Håkon Reikvam and Øystein Bruserud
DOI: 10.2174/138920101701151027163600
Practical Considerations for Omics Experiments in Biomedical Sciences
, 17(1): 105 - 114Marc Vaudel, Harald Barsnes, Rolf Bjerkvig, Andreas Bikfalvi, Frode Selheim, Frode S Berven and Thomas Daubon
DOI: 10.2174/1389201016666150817095348
Editor-in-Chief
Nikolaos Labrou
School of Food, Biotechnology and Development
Department of Biotechnology
Agricultural University of Athens
Athens
(Greece)
Biography
School of Food, Biotechnology and Development
Department of Biotechnology
Agricultural University of Athens
Athens
Biography
Biography of Nikolaos Labrou
Dr. Nikolaos Labrou is a Full Professor with tenure and Director of the Enzyme Technology Lab at the Agricultural University of Athens, Greece. His research takes place where molecular enzymology, biochemistry, and pharmaceutical biotechnology meets and covers aspects of the entire range from pure to applied science. The principal area of his research program has been the mining, design, and exploitation of biocatalytic diversity. Dr. Labrou has authored more than 160 peer-reviewed articles in leading international journals and has edited six books. He is on the Editorial Board of several scientific journals and serves as a reviewer for multiple national and international grant agencies. He has established a strong global academic and industrial network and maintains international collaborations with several research groups at various institutions across the world.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net